238 related articles for article (PubMed ID: 22659843)
21. Interleukin 1 β-induced SMAD2/3 linker modifications are TAK1 dependent and delay TGFβ signaling in primary human mesenchymal stem cells.
van den Akker GG; van Beuningen HM; Vitters EL; Koenders MI; van de Loo FA; van Lent PL; Blaney Davidson EN; van der Kraan PM
Cell Signal; 2017 Dec; 40():190-199. PubMed ID: 28943409
[TBL] [Abstract][Full Text] [Related]
22. Long Noncoding RNA
Sakai S; Ohhata T; Kitagawa K; Uchida C; Aoshima T; Niida H; Suzuki T; Inoue Y; Miyazawa K; Kitagawa M
Cancer Res; 2019 Jun; 79(11):2821-2838. PubMed ID: 30952633
[TBL] [Abstract][Full Text] [Related]
23. Hsa-miR-5582-3P regulatory effect on TGFβ signaling through targeting of TGFβ-R1, TGFβ-R2, SMAD3, and SMAD4 transcripts.
Abedini Bakhshmand E; Mohammad Soltani B; Fasihi A; Mowla SJ
J Cell Biochem; 2018 Dec; 119(12):9921-9930. PubMed ID: 30129155
[TBL] [Abstract][Full Text] [Related]
24. Differential regulation of transforming growth factor beta signaling pathways by Notch in human endothelial cells.
Fu Y; Chang A; Chang L; Niessen K; Eapen S; Setiadi A; Karsan A
J Biol Chem; 2009 Jul; 284(29):19452-62. PubMed ID: 19473993
[TBL] [Abstract][Full Text] [Related]
25. Novel regulation of Smad3 oligomerization and DNA binding by its linker domain.
Vasilaki E; Siderakis M; Papakosta P; Skourti-Stathaki K; Mavridou S; Kardassis D
Biochemistry; 2009 Sep; 48(35):8366-78. PubMed ID: 19645436
[TBL] [Abstract][Full Text] [Related]
26. ELL Protein-associated Factor 2 (EAF2) Inhibits Transforming Growth Factor β Signaling through a Direct Interaction with Smad3.
Liu X; Chen Z; Ouyang G; Song T; Liang H; Liu W; Xiao W
J Biol Chem; 2015 Oct; 290(43):25933-45. PubMed ID: 26370086
[TBL] [Abstract][Full Text] [Related]
27. Phosphorylation status at Smad3 linker region modulates transforming growth factor-β-induced epithelial-mesenchymal transition and cancer progression.
Ooshima A; Park J; Kim SJ
Cancer Sci; 2019 Feb; 110(2):481-488. PubMed ID: 30589983
[TBL] [Abstract][Full Text] [Related]
28. The proinflammatory LTB4/BLT1 signal axis confers resistance to TGF-β1-induced growth inhibition by targeting Smad3 linker region.
Jeon WK; Choi J; Park SJ; Jo EJ; Lee YK; Lim S; Kim JH; Letterio JJ; Liu F; Kim SJ; Kim BC
Oncotarget; 2015 Dec; 6(39):41650-66. PubMed ID: 26497676
[TBL] [Abstract][Full Text] [Related]
29. A role of TGFß1 dependent 14-3-3σ phosphorylation at Ser69 and Ser74 in the regulation of gene transcription, stemness and radioresistance.
Zakharchenko O; Cojoc M; Dubrovska A; Souchelnytskyi S
PLoS One; 2013; 8(5):e65163. PubMed ID: 23741479
[TBL] [Abstract][Full Text] [Related]
30. KLF17 empowers TGF-β/Smad signaling by targeting Smad3-dependent pathway to suppress tumor growth and metastasis during cancer progression.
Ali A; Zhang P; Liangfang Y; Wenshe S; Wang H; Lin X; Dai Y; Feng XH; Moses R; Wang D; Li X; Xiao J
Cell Death Dis; 2015 Mar; 6(3):e1681. PubMed ID: 25766320
[TBL] [Abstract][Full Text] [Related]
31. Heterodimer formation by Oct4 and Smad3 differentially regulates epithelial-to-mesenchymal transition-associated factors in breast cancer progression.
Mandal G; Biswas S; Roy Chowdhury S; Chatterjee A; Purohit S; Khamaru P; Chakraborty S; Mandal PK; Gupta A; de la Mare JA; Edkins AL; Bhattacharyya A
Biochim Biophys Acta Mol Basis Dis; 2018 Jun; 1864(6 Pt A):2053-2066. PubMed ID: 29526821
[TBL] [Abstract][Full Text] [Related]
32. A new model of anterior subcapsular cataract: involvement of TGFbeta/Smad signaling.
Shirai K; Saika S; Tanaka T; Okada Y; Flanders KC; Ooshima A; Ohnishi Y
Mol Vis; 2006 Jun; 12():681-91. PubMed ID: 16807527
[TBL] [Abstract][Full Text] [Related]
33. A Smad3 transgenic reporter reveals TGF-beta control of zebrafish spinal cord development.
Casari A; Schiavone M; Facchinello N; Vettori A; Meyer D; Tiso N; Moro E; Argenton F
Dev Biol; 2014 Dec; 396(1):81-93. PubMed ID: 25286120
[TBL] [Abstract][Full Text] [Related]
34. TGFβ/Smad3 regulates proliferation and apoptosis through IRS-1 inhibition in colon cancer cells.
Bailey KL; Agarwal E; Chowdhury S; Luo J; Brattain MG; Black JD; Wang J
PLoS One; 2017; 12(4):e0176096. PubMed ID: 28414818
[TBL] [Abstract][Full Text] [Related]
35. Activin A mediates growth inhibition and cell cycle arrest through Smads in human breast cancer cells.
Burdette JE; Jeruss JS; Kurley SJ; Lee EJ; Woodruff TK
Cancer Res; 2005 Sep; 65(17):7968-75. PubMed ID: 16140969
[TBL] [Abstract][Full Text] [Related]
36. MTMR4 attenuates transforming growth factor beta (TGFbeta) signaling by dephosphorylating R-Smads in endosomes.
Yu J; Pan L; Qin X; Chen H; Xu Y; Chen Y; Tang H
J Biol Chem; 2010 Mar; 285(11):8454-62. PubMed ID: 20061380
[TBL] [Abstract][Full Text] [Related]
37. Erbin inhibits transforming growth factor beta signaling through a novel Smad-interacting domain.
Dai F; Chang C; Lin X; Dai P; Mei L; Feng XH
Mol Cell Biol; 2007 Sep; 27(17):6183-94. PubMed ID: 17591701
[TBL] [Abstract][Full Text] [Related]
38. SMAD3 and SMAD4 have a more dominant role than SMAD2 in TGFβ-induced chondrogenic differentiation of bone marrow-derived mesenchymal stem cells.
de Kroon LM; Narcisi R; van den Akker GG; Vitters EL; Blaney Davidson EN; van Osch GJ; van der Kraan PM
Sci Rep; 2017 Feb; 7():43164. PubMed ID: 28240243
[TBL] [Abstract][Full Text] [Related]
39. Hepatitis B virus X protein shifts human hepatic transforming growth factor (TGF)-beta signaling from tumor suppression to oncogenesis in early chronic hepatitis B.
Murata M; Matsuzaki K; Yoshida K; Sekimoto G; Tahashi Y; Mori S; Uemura Y; Sakaida N; Fujisawa J; Seki T; Kobayashi K; Yokote K; Koike K; Okazaki K
Hepatology; 2009 Apr; 49(4):1203-17. PubMed ID: 19263472
[TBL] [Abstract][Full Text] [Related]
40. The tumor suppressor KLF11 mediates a novel mechanism in transforming growth factor beta-induced growth inhibition that is inactivated in pancreatic cancer.
Buck A; Buchholz M; Wagner M; Adler G; Gress T; Ellenrieder V
Mol Cancer Res; 2006 Nov; 4(11):861-72. PubMed ID: 17114344
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
